Multiple Myeloma in a Patient with Acromegaly
Endocrinology and Metabolism
;
: 110-115, 2015.
Artículo
en Inglés
| WPRIM
| ID: wpr-150110
ABSTRACT
Acromegaly is a slowly progressing condition resulting from excess growth hormone (GH), generally caused by a GH-secreting pituitary adenoma. Cancer is the third most common cause of mortality in patients with acromegaly, and insulin-like growth factor 1 (IGF-1) is known to influence tumor formation by increasing cell proliferation and inhibiting apoptosis. Multiple myeloma (MM) is a plasma cell neoplasm, and previous studies have suggested the possible role of IGF-1 in its development of MM. However, no cases of acromegaly accompanied with MM have been reported in Asia to date. We here report the case of a 58-year-old woman with acromegaly accompanied with MM who presented with longstanding acromegalic manifestations resulting from a GH-secreting pituitary adenoma and also exhibited anemia, a reversed albumin/globulin ratio, and plasmacytosis on bone marrow examination. Because IGF-1 has been suggested to play an important role in the development and progression of MM, the patient promptly underwent surgical removal of the pituitary adenoma via a transsphenoidal approach. Since there is currently no consensus on therapeutic guidelines and suggested prognosis for MM with acromegaly, long-term follow-up of such cases is needed.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Neoplasias Hipofisarias
/
Pronóstico
/
Asia
/
Acromegalia
/
Examen de la Médula Ósea
/
Factor I del Crecimiento Similar a la Insulina
/
Hormona del Crecimiento
/
Mortalidad
/
Apoptosis
/
Consenso
Tipo de estudio:
Guía de Práctica Clínica
/
Estudio pronóstico
Límite:
Femenino
/
Humanos
País/Región como asunto:
Asia
Idioma:
Inglés
Revista:
Endocrinology and Metabolism
Año:
2015
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS